Axogen (AXGN) Income from Non-Controlling Interests (2024)
Axogen's (AXGN) quarterly Income from Non-Controlling Interests came in at $90000.0 in Q3 2024.
Axogen (AXGN) Income from Non-Controlling Interests (2024) Analysis & Trends
Axogen's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $90000.0 for Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Axogen | 2.11 Bn | 2.01 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 90,000.00 |